Clinical and Biochemical Aspects of Carnitine Deficiency and Insufficiency: Transport Defects and Inborn Errors of β-Oxidation

References

• Angelini C. Heterogeneity of lipid storage myopathies. Neuromuscular disease, G Serratrice, D Gross, C Desnuelle, et al. Raven Press, New York 1992; 87–94
   Google Scholar
• Bieber L L. Carnitine. Annu Rev Biochem 1988; 57: 261–83
   PubMed Web of Science ®Google Scholar
• Veerkamp J H., Paulussen R JA. Fatty acid transport in muscle: the role of fatty acid-binding proteins. Biochem Soc Trans 1987; 15: 331–36
   PubMed Web of Science ®Google Scholar
• Stremmel W. Fatty acid uptake by isolated rat heart myocytes represents a carrier-mediated transport process. J Clin Invest 1988; 81: 844–52
   PubMed Web of Science ®Google Scholar
• Knudsen J. Acyl-CoA-binding protein (ACBP) and its relation to fatty acid-binding protein (FABP): an overview. Mol Cell Biochem 1990; 98: 217–23
   PubMed Web of Science ®Google Scholar
• Finocchiaro G, Taroni F, Rocchi M, et al. cDNA cloning, sequence analysis, and chromosomal localization of the gene for human carnitine palmitoyltransferase. Proc Natl Acad Sci USA 1991; 88: 661–65
   PubMed Web of Science ®Google Scholar
• Schulz H. Mitochondrial ß-oxidation. Fatty acid oxidation: clinical, biochemical and molecular aspects, K Tanaka, P M. Coates. Alan Liss, New York 1990; 23–36
   Google Scholar
• Finocchiaro G, Ito M, Dceda Y, et al. Molecular cloning and nucleotide sequence of cDNA encoding the α-subunit of human electron transfer flavoprotein. J Biol Chem 1988; 263: 15773–80
   PubMed Web of Science ®Google Scholar
• El-Fakhrim M, Middleton B. The existence of one inner-membrane-bound, long chain specific 3-hydroxyacyl-CoA dehydrogenase in mammalian mitochondria. Biochim Biophys Acta 1982; 713: 270
   PubMed Web of Science ®Google Scholar
• Gregersen N. The acyl-CoA dehydrogenation deficiencies. Scand J Clin Lab Invest 1985; 45: 11–60
   PubMed Web of Science ®Google Scholar
• Editorial. Sudden infant death and inherited disorder of fat oxidation. Lancet 1986; 11: 1073–75
   Google Scholar
• Chalmers R A., Roe C R., Tracey B M., et al. Secondary carnitine insufficiency in disorders of organic acid metabolism. Modulation of acylCo A/CoA ratios by L-carnitine in vivo. Biochem Soc Trans 1983; 11: 724–25
   Google Scholar
• Brass E P. Carnitine transport. L-carnitine and its role in medicine: from function to therapy, R Ferrari, S DiMauro, G Sherwood. Academic Press, New York 1992; 21–36
   Google Scholar
• Martinuzzi A, Vergani L, Rosa M, et al. L-Carnitine uptake in differentiating human cultured muscle. Biochim Biophys Acta 1991; 1095: 217–22
   PubMed Web of Science ®Google Scholar
• Engel A G., Angelini C. Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science 1973; 173: 899–902
   Google Scholar
• Angelini C, Lucke S, Cantarutti F. Carnitine deficiency of skeletal muscle: report of a treated case. Neurology 1976; 26: 633–37
   PubMed Web of Science ®Google Scholar
• Angelini C, Martinuzzi A, Vergani L. Treatment with L-carnitine of the infantile and adult form of primary carnitine deficiency. L-carnitine and its role in medicine: from function to therapy, R Ferrari, S DiMauro, G Sherwood. Academic Press, New York 1991; 139–53
   Google Scholar
• Rebouche C J., Engel A G. Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes: evidence for alterations in tissue carnitine transport. J Clin Invest 1984; 73: 857–67
   PubMed Web of Science ®Google Scholar
• Treem W R., Stanley C A., Finegold D N., et al. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle and fibroblasts. N Engl J Med 1988; 319: 1331–36
   PubMed Web of Science ®Google Scholar
• Eriksson B O., Gustafson B, Lindstedt S, et al. Transport of carnitine into cells in hereditary carnitine deficiency. J Inher Metab Dis 1989; 12: 108–11
   PubMed Web of Science ®Google Scholar
• Tein I, De Vivo D C., Bierman F, et al. Impaired skin fibroblasts carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediatr Res 1990; 28: 247–55
   PubMed Web of Science ®Google Scholar
• Chapoy P R., Angelini C, Brown W J., et al. Systemic carnitine deficiency. A treatable inherited lipid-storage disease presenting as Reye's syndrome. N Engl J Med 1980; 303: 1389–94
   PubMed Web of Science ®Google Scholar
• Tripp M E., Katcher M L., Peters H A., et al. Systemic carnitine deficiency presenting as familial endocardial fibroelastosis. A treatable cardiomyopathy. N Engl J Med 1981; 305: 385–90
   PubMed Web of Science ®Google Scholar
• Waber L I., Valle D, Neil C, et al. Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport. J Pediatr 1982; 101: 700–5
   PubMed Web of Science ®Google Scholar
• Pereira Rodriguez R., Sholte H R., Luyt-Houwen I EM, et al. Cardiomyopathy associated with carnitine loss in kidneys and small intestine. Eur J Pediatr 1988; 148: 193–197
   PubMed Web of Science ®Google Scholar
• Von Petrykowski W, Ketelsen U P., Schmidt-Sommerfeld E, et al. Primary systemic carnitine deficiency under successful therapy: clinical, biochemical, ultrahistochemical and renal clearance studies. Clin Neuropathol 1985; 4: 63–71
   PubMed Web of Science ®Google Scholar
• DiMauro S, DiMauro-Melis P. Muscle carnitine palmityl transferase deficiency and myoglobinuria. Science 1973; 182: 929–31
   PubMed Web of Science ®Google Scholar
• Angelini C, Freddo L, Battistella P, et al. Carnitine palmityl transferase deficiency: clinical variability, carrier detection, and autosomal recessive inheritance. Neurology 1981; 31: 883–86
   PubMed Web of Science ®Google Scholar
• Trevisan C P., Angelini C, Freddo L, et al. Myoglobinuria and carnitine palmityl transferase (CPT) deficiency: Studies with malonyl-CoA suggest absence of only CPT II. Neurology 1984; 34: 353–56
   PubMed Web of Science ®Google Scholar
• Trevisan C P., Isaya G, Angelini C. Exercise-induced recurrent myoglobinuria: defective activity of inner carnitine palmitoyl transferase in muscle mitochondria of two patients. Neurology 1987; 37: 1184–88
   PubMed Web of Science ®Google Scholar
• Verderio E, Gellera C, Cavadini P, et al. A missense mutation in the carnitine palmitoyltransferase gene causing carnitine palmitoyltransferase deficiency and myopathy. J Neurol 1992; 239(Suppl. 2)S58
   Google Scholar
• Taroni F, Verderio E, Gellera C, et al. The molecular basis of carnitine palmitoyltransferase deficiency. J Neurol 1992; 239(Suppl. 2)S58
   Google Scholar
• Demaugre F, Bennefont J P., Mitchell G, et al. Hepatic and muscular presentations of carnitine palmitolyl transferase deficiency: two distinct entities. Pediatr Res 1988; 24: 308–11
   PubMed Web of Science ®Google Scholar
• Hug G, Bove K E., Soukup S. Lethal neonatal multiorgan deficiency of carnitine palmitoyl transferase. II. N Engl J Med 1991; 325: 1862–64
   PubMed Web of Science ®Google Scholar
• Stanley C A., Hale D E., Berry G T., et al. Brief report: a deficiency of carnitine acyl-carnitine translocase in the inner mitochondrial membrane. N Engl J Med 1992; 327: 19–23
   PubMed Web of Science ®Google Scholar
• Rinaldo P, O'Shea J J., Coates P M., et al. Medium-chain acyl-CoA dehydrogenase deficiency. N Engl J Med 1988; 319: 1308–13
   PubMed Web of Science ®Google Scholar
• Hale D E., Batshaw M L., Coates P M., et al. Long-chain acyl-coenzyme A dehydrogenase deficiency: an inherited cause of non-ketotic hypoglycemia. Pediatr Res 1985; 19: 666–71
   PubMed Web of Science ®Google Scholar
• Hale D E., Stanley C A., Coates P M. The long chain acyl-CoA dehydrogenase deficiency. Fatty acid oxidation: clinical, biochemical and molecular aspects, K Tanaka, P M. Coates. Alan Liss, New York 1990; 303–11
   Google Scholar
• Indo Y, Coates P M., Hale D E., et al. Immunochemical characterization of variant long-chain acyl-CoA dehydrogenase in cultured fibroblasts from nine patients with long-chain acyl-CoA dehydrogenase in cultured fibroblasts from nine patients with long-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 1991; 30: 211–15
   PubMed Web of Science ®Google Scholar
• Kolvraa S, Gregersen N, Christensen E, et al. In vitro fibroblasts studies in a patient with C6-C10 dicarboxylic aciduria: evidence for a defect in general acyl-CoA dehydrogenase. Clin Chim Acta 1982; 126: 53–67
   PubMed Web of Science ®Google Scholar
• Chalmers R A., Lawson A M., Whitelaw A, et al. Twin siblings with Reye-like syndrome associated with an abnormal aciduria, hypoglycemia, diarrhea and vomiting with close similarities to Jamaican vomiting sickness. Pediatr Res 1980; 14: 1097–1103
   PubMed Web of Science ®Google Scholar
• Valle Delia A., Garcia M J., Merinero B, et al. A new patient with dicarboxylic aciduria suggestive of M-CAD deficiency presenting as Reye's syndrome. J Inker Metab Dis 1984; 7: 62–64
   PubMed Web of Science ®Google Scholar
• Roe C R., Millington D S., Maltby D A. Recognition of M-CAD deficiency in asymptomatic siblings of children dying of a sudden infant death or Reye-like syndromes. J Pediatr 1986; 108: 13–18
   PubMed Web of Science ®Google Scholar
• Zierz S, Engei A G., Romshe C A. Assay of acyl-CoA dehydrogenases in muscle and liver and identification of four new cases of M-CAD deficiency associated with systemic carnitine deficiency. Adv Neurol 1988; 48: 231–37
   PubMedGoogle Scholar
• Roe C R., Coates P M. Acyl-CoA dehydrogenase deficiencies. The metabolic basis of inherited disease, C R. Scriver, A L. Beaudet, W S. Sly, et al. McGraw-Hill, New York 1989; 889–914
   Google Scholar
• Engel A G., Rebouche C J., Wilson D M., et al. Primary systemic carnitine deficiency. II. Renal handling of carnitine. Neurology 1981; 31: 819–25
   PubMed Web of Science ®Google Scholar
• Traumer D A., Huttenlocher P R. Short chain fatty acid-induced central hyperventilation in rabbits. Neurology 1978; 28: 940–44
   PubMed Web of Science ®Google Scholar
• Roe C R., Millington D S., Maltby D A., et al. Diagnostic and therapeutic implications of medium chain acylcarnitines in the medium chain acyl-CoA dehydrogenase deficiency. Pediatr Res 1985; 19: 459–66
   PubMed Web of Science ®Google Scholar
• Matsubara Y, Narisawa K, Tada K. Medium chain acyl-CoA dehydrogenase deficiency: molecular aspects. Eur J Pediatr 1992; 151: 154–59
   PubMed Web of Science ®Google Scholar
• Yokota I, Coates P M., Hale D E., et al. Molecular survey of a prevalent mutation, 985A-to-G transition, and identification of five infrequent mutations in the medium-chain acyl-CoA dehydrogenase (MCAD) gene in 55 patients with MCAD deficiency. Am J Hum Genet 1991; 49: 1280–91
   PubMed Web of Science ®Google Scholar
• Tumbull D M., Bartlett K, Stevens D L., et al. Short chain acyl-CoA dehydrogenase associated with lipid storage myopathy and secondary carnitine deficiency. N Engl J Med 1984; 311: 1232–36
   PubMed Web of Science ®Google Scholar
• Amendt B A., Greene C, Sweetman L, et al. Short chain acyl-coenzyme A dehydrogenase deficiency. Clinical and biochemical studies in two patients. J Clin Invest 1987; 79: 1303–9
   PubMed Web of Science ®Google Scholar
• Coates P M., Hale D E., Finocchiaro G, et al. Genetic deficiency of short chain acyl coenzyme A dehydrogenase from a patient with muscle carnitine deficiency and severe muscle weakness. J Clin Invest 1988; 81: 171–75
   PubMed Web of Science ®Google Scholar
• Naito E, Ozasa I, Ikeda Y, et al. Molecular cloning and nucleotide sequence of complementary DNAs encoding human short chain acyl-coenzyme A dehydrogenase and the study of the molecular basis of human short chain acyl-CoA dehydrogenase deficiency. J Clin Invest 1989; 83: 1605–13
   PubMed Web of Science ®Google Scholar
• Naito E, Indo Y, Tanaka K. Short chain acyl-coenzyme A dehydrogenase (SCAD) deficiency. Immunochemical demonstration of molecular heterogeneity due to variant SCAD with differing stability. J Clin Invest 1989; 84: 1971–74
   Web of Science ®Google Scholar
• Naito E, Indo Y, Tanaka K. Identification of two variant short chain acyl-coenzyme A dehydrogenase alleles, each containing a different point mutation in a patient with short chain acyl-coenzyme A dehydrogenase deficiency. J Clin Invest 1990; 85: 1575–82
   PubMed Web of Science ®Google Scholar
• Farnsworth L, Shepherd I M., Johnson M A., et al. Absence of immunoreactive enzyme protein in short-chain acylcoenzyme A dehydrogenase deficiency. Ann Neurol 1990; 28: 717–20
   PubMed Web of Science ®Google Scholar
• Tumbull D M., Shepherd I M., Ashworth B, et al. Lipid storage myopathy associated with low acyl-CoA dehydrogenase activities. Brain 1988; 111: 815–28
   PubMed Web of Science ®Google Scholar
• DiDonato S, Gellera C, Peluchetti D, et al. Normalization of short chain acylcoenzyme A dehydrogenase after riboflavin treatment in a girl with multiple acylcoenzyme A dehydrogenase deficient myopathy. Ann Neurol 1989; 25: 479–84
   PubMed Web of Science ®Google Scholar
• Angelini C, Govoni E, Bragaglia M M., et al. Carnitine deficiency: acute postpartum crisis. Ann Neurol 1978; 4: 558–61
   PubMed Web of Science ®Google Scholar
• Angelini C, Vergani L, Martinuzzi A, et al. Hereditary protein C deficiency associated with lipid storage myopathy riboflavin responsive. J Neurol 1992; 239(Suppl. 2)S85
   Google Scholar
• Glasgow A M., Engel A G., Bier D M., et al. Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcarnitine excess responsive to medium chain triglyceride diet. Pediatr Res 1983; 17: 319–26
   PubMed Web of Science ®Google Scholar
• Hale D E., Thorpe C, Braat K, et al. The L-3-hydroxyacyl-CoA dehydrogenase deficiency. Fatty acid oxidation: clinical, biochemical and molecular aspects, K Tanaka, P M. Coates. Alan Liss, New York 1990; 503–10
   Google Scholar
• Wanders R JA, Ijlst L, Van Gennip A H., et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid ß-oxidation. J Inker Metab Dis 1990; 13: 311–14
   PubMed Web of Science ®Google Scholar
• Rocchiccioli F, Wanders R JA, Aubourg P, et al. Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood. Pediatr Res 1990; 28: 657–62
   PubMed Web of Science ®Google Scholar
• Pollitt R J. Clinical and biochemical presentation in twenty cases of hydroxydicarboxylic aciduria. Fatty acid oxidation: clinical, biochemical and molecular aspects, K Tanaka, P M. Coates. Alan Liss, New York 1990; 495–502
   Google Scholar
• Carpenter S, Middleton B, Pollitt R J. The long-chain 3-hydroxyacyl-CoA dehydrogenase of human liver mitochondria. J Inker Metab Dis 1991; 14: 321–24
   PubMed Web of Science ®Google Scholar
• Wanders R JA, Ijlst L, Duran M, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: different clinical expression in three unrelated patients. J Inker Metab Dis 1991; 14: 325–28
   PubMed Web of Science ®Google Scholar
• Jackson S, Bartlett K, Land J, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res 1991; 29: 406–11
   PubMed Web of Science ®Google Scholar
• Bertini E, Dionisi-Vici C, Garavaglia B, et al. Periphreal sensory-motor polyneuropathy, pigmentary retinopathy, and fatal cardiomyopathy in long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency. Eur J Pediatr 1992; 151: 121–26
   PubMed Web of Science ®Google Scholar
• Riudor E, Ribes A, Boronat M, et al. A new case of C6-C14 dicarboxylic aciduria with favourable evolution. J Inker Metab Dis 1986; 9: 297–99
   PubMed Web of Science ®Google Scholar
• Kelly R I., Morton D H. 3-Hydroxyoctanoic aciduria: identification of a new organic acid in the urine of a patient with non-ketotic hypoglycemia. Clin Chim Acta 1988; 175: 19–26
   PubMed Web of Science ®Google Scholar
• Pollitt R J., Losty H, Westwood A. 3-Hydroxydicarboxylic aciduria: a distinctive type of intermittent dicarboxylic aciduria of possible diagnostic significance. J Inker Metab Dis 1987; 10: 266–69
   Web of Science ®Google Scholar
• Poll-The B T., Bonnefont J P., Ogier H, et al. Familial hypoketotic hypoglycaemia associated with peripheral neuropathy, pigmentary retinopathy and C6-C14 hydroxydicarboxylic aciduria. A new defect in fatty acid oxidation. J Inker Metab Dis 1988; 11: 183–85
   PubMed Web of Science ®Google Scholar
• Przyrembel H, Jakobs C, Ijlst L, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inker Metab Dis 1991; 14: 674–80
   PubMed Web of Science ®Google Scholar
• Przyrembel H, Wendel U, Becker K, et al. Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta 1976; 66: 227–39
   PubMed Web of Science ®Google Scholar
• Frerman F E., Goodman S I. Deficiency of electron transfer flavoprotein or electron transfer flavoprotein-ubiquinone oxidoreductase in glutaric acidemia type II fibroblasts. Proc Natl AcadSci USA 1985; 82: 4517–20
   PubMed Web of Science ®Google Scholar
• Mantagos S, Genel M, Tanaka K. Ethylmalonic-adipic aciduria. In vivo and in vitro studies indicating deficiency of activities of multiple acyl-CoA dehydrogenase. J Clin Invest 1979; 64: 1580–89
   PubMed Web of Science ®Google Scholar
• Bell R B., Brownell A KW, Roe C R., et al. Electron transfer flavoprotein: ubiquinone oxidoreductase (ETF:QO) deficiency in an adult. Neurology 1990; 40: 1779–82
   PubMed Web of Science ®Google Scholar
• DiDonato S, Frerman F E., Rimoldi M, et al. Systemic carnitine deficiency due to lack of electron transfer flavoprotein: ubiquinone reductase. Neurology 1986; 36: 957–63
   PubMed Web of Science ®Google Scholar
• Isai K, Uchida Y, Orii T, et al. Novel fatty acid ß-oxidation enzymes in rat liver mitochondria. J Biol Chem 1992; 267: 1027–33
   PubMed Web of Science ®Google Scholar